These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 26952483)
1. Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study. Kiani M; Mirzazadeh Tekie FS; Dinarvand M; Soleimani M; Dinarvand R; Atyabi F Mater Sci Eng C Mater Biol Appl; 2016 May; 62():771-8. PubMed ID: 26952483 [TBL] [Abstract][Full Text] [Related]
2. Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer. Dinarvand M; Kiani M; Mirzazadeh F; Esmaeili A; Mirzaie Z; Soleimani M; Dinarvand R; Atyabi F Int J Biol Macromol; 2015; 78():112-21. PubMed ID: 25858880 [TBL] [Abstract][Full Text] [Related]
3. Nano polyelectrolyte complexes of carboxymethyl dextran and chitosan to improve chitosan-mediated delivery of miR-145. Tekie FS; Kiani M; Zakerian A; Pilevarian F; Assali A; Soleimani M; Dinarvand R; Arefian E; Atashi A; Amini M; Atyabi F Carbohydr Polym; 2017 Mar; 159():66-75. PubMed ID: 28038755 [TBL] [Abstract][Full Text] [Related]
4. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity. Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312 [TBL] [Abstract][Full Text] [Related]
5. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Moghaddam FA; Atyabi F; Dinarvand R Nanomedicine; 2009 Jun; 5(2):208-15. PubMed ID: 19186220 [TBL] [Abstract][Full Text] [Related]
7. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441 [TBL] [Abstract][Full Text] [Related]
8. Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment. Tekie FSM; Soleimani M; Zakerian A; Dinarvand M; Amini M; Dinarvand R; Arefian E; Atyabi F Carbohydr Polym; 2018 Dec; 201():131-140. PubMed ID: 30241804 [TBL] [Abstract][Full Text] [Related]
9. Characterization of chitosan-carboxymethyl dextran nanoparticles as a drug carrier and as a stimulator of mouse splenocytes. Lin YS; Radzi R; Morimoto M; Saimoto H; Okamoto Y; Minami S J Biomater Sci Polym Ed; 2012; 23(11):1401-20. PubMed ID: 21740648 [TBL] [Abstract][Full Text] [Related]
10. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318 [TBL] [Abstract][Full Text] [Related]
11. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Yin L; Ding J; He C; Cui L; Tang C; Yin C Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo. Sudhakar S; Chandran SV; Selvamurugan N; Nazeer RA Int J Biol Macromol; 2020 May; 150():281-288. PubMed ID: 32057846 [TBL] [Abstract][Full Text] [Related]
13. hSET1: a novel approach for colon cancer therapy. Yadav S; Singhal J; Singhal SS; Awasthi S Biochem Pharmacol; 2009 May; 77(10):1635-41. PubMed ID: 19426701 [TBL] [Abstract][Full Text] [Related]
14. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
15. Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting. Asthana GS; Asthana A; Kohli DV; Vyas SP Biomed Res Int; 2014; 2014():526391. PubMed ID: 25057492 [TBL] [Abstract][Full Text] [Related]
16. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575 [TBL] [Abstract][Full Text] [Related]
17. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells. Talaei F; Azizi E; Dinarvand R; Atyabi F Int J Nanomedicine; 2011; 6():1963-75. PubMed ID: 21976973 [TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery. Samprasit W; Opanasopit P; Chamsai B Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571 [TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423 [TBL] [Abstract][Full Text] [Related]
20. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]